Skip to main content
. 2015 Jul-Aug;32(4):331–338. doi: 10.4103/0970-2113.159559

Figure 5.

Figure 5

Photographs showing in vitro anti-tubercular activity. (a) Pure Rifampicin. (b) Formulation FDFL4